Article

Acrylic lenses produce virtually no PCO

The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart.

The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart, according to Filippo Simona from the LaserVis Refractive Centre, Locarno, Switzerland.

In a prospective, non-randomized pilot study, 116 eyes of 78 patients with senile cataract underwent phacoemulsification and implantation of the acylic *Acri.Lyc 356 (35 eyes) or the silicone *Acri.Tec 737 (81 eyes).

The results showed that both lenses provided both good near and distance visual acuity, however, the acrylic lens produced hardly any PCO, just 1% compared with 14% in the silicone group.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.